TARDBP and supranuclear palsy, progressive, 1: The present study aimed to determine the frequency of patients who were clinically diagnosed with PSP, although their underlying pathology was confirmed FTLD-TDP (FTLD-TDP-PSP) and to characterize their clinical and pathological features, focusing on neuronal loss and TDP-43 pathology.